Dark Forest Capital Management LP Has $130,000 Holdings in Sotera Health (NASDAQ:SHC)

Dark Forest Capital Management LP decreased its position in shares of Sotera Health (NASDAQ:SHC) by 73.0% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 10,984 shares of the company’s stock after selling 29,767 shares during the quarter. Dark Forest Capital Management LP’s holdings in Sotera Health were worth $130,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of SHC. CWM LLC grew its holdings in Sotera Health by 86.1% during the 2nd quarter. CWM LLC now owns 2,146 shares of the company’s stock worth $25,000 after acquiring an additional 993 shares during the last quarter. Point72 DIFC Ltd grew its stake in shares of Sotera Health by 556.6% in the second quarter. Point72 DIFC Ltd now owns 6,540 shares of the company’s stock worth $78,000 after purchasing an additional 5,544 shares during the last quarter. Acadian Asset Management LLC grew its stake in shares of Sotera Health by 728.0% in the second quarter. Acadian Asset Management LLC now owns 9,381 shares of the company’s stock worth $111,000 after purchasing an additional 8,248 shares during the last quarter. Sandia Investment Management LP acquired a new stake in Sotera Health in the first quarter valued at $120,000. Finally, Securian Asset Management Inc. raised its position in Sotera Health by 23.0% during the 1st quarter. Securian Asset Management Inc. now owns 10,178 shares of the company’s stock worth $122,000 after purchasing an additional 1,900 shares during the last quarter. Institutional investors own 91.03% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have commented on the company. Royal Bank of Canada reiterated an “outperform” rating and issued a $17.00 price target on shares of Sotera Health in a research report on Tuesday, August 6th. Barclays increased their target price on shares of Sotera Health from $14.00 to $17.00 and gave the company an “overweight” rating in a research report on Tuesday, August 6th. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $15.70.

Insider Buying and Selling

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of Sotera Health stock in a transaction on Friday, September 6th. The shares were sold at an average price of $15.03, for a total value of $150,300,000.00. Following the completion of the sale, the director now directly owns 49,215,301 shares of the company’s stock, valued at $739,705,974.03. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. 55.12% of the stock is owned by insiders.

Sotera Health Stock Down 0.4 %

Shares of Sotera Health stock opened at $16.70 on Tuesday. The stock’s 50-day moving average is $15.32 and its 200 day moving average is $12.95. Sotera Health has a one year low of $10.71 and a one year high of $17.44. The firm has a market cap of $4.73 billion, a price-to-earnings ratio of 87.89 and a beta of 2.07. The company has a debt-to-equity ratio of 5.46, a current ratio of 2.93 and a quick ratio of 2.59.

Sotera Health (NASDAQ:SHC) last posted its quarterly earnings results on Monday, August 5th. The company reported $0.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.15 by $0.04. The firm had revenue of $277.00 million for the quarter, compared to analysts’ expectations of $266.45 million. Sotera Health had a return on equity of 47.26% and a net margin of 3.65%. The company’s revenue for the quarter was up 8.6% compared to the same quarter last year. During the same period in the prior year, the business earned $0.19 EPS. Equities research analysts anticipate that Sotera Health will post 0.64 EPS for the current year.

Sotera Health Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.